NCT05717335View on ClinicalTrials.gov

Observational Pilot Study With TachoSil as a Ventricular Sealant

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

May 1, 2022

Primary Completion Date

February 3, 2023

Study Completion Date

February 3, 2023

Conditions
Intraventricular Neoplasm
Interventions
DRUG

TachoSil

Placement of TachoSil over the ventricular entry point in patients with periventricular lesions in order to avoid complications related to the ventricular entry.

Trial Locations (1)

08916

Hospital Universitari Germans Trias i Pujol, Badalona

All Listed Sponsors
lead

Germans Trias i Pujol Hospital

OTHER